• Home
• Publications
  • CodeMap Premier Package
  • CodeMap Standard Package
  • Lab Reimbursement Manual
  • Lab Medical Necessity Guide
  • Lab CCI Manual
• Data Files
  • ICD-10 Medical Necessity
    • Hospital Data Sets
    • Laboratory Data Sets
    • Radiology Data Sets
    • Covered Medicare Contractors
    • Technical FAQ
    • Pre-Sales FAQ
    • Support
    • Data File Partners
  • ICD-10 Descriptor File
  • CLIA Database
  • Support
  • Order Form
• CodeMap® Online
  • About CodeMap® Online
  • ICD-10 Search
  • Procedure Hierarchy
  • CCI/MUE Edit Report
  • Medical Necessity Check
  • NPI Market Analysis Search
  • LCDs and Articles by Medicare Contractor
  • National Coverage Determinations (NCDs)
  • Latest LCD Report
  • Upcoming LCD Revisions
  • Order Now
• Industry Resources
  • Using Part B Medicare Claims Data to Project Market Size and Growth
  • Using Medicare Claims Data / CLIA Certificate Data to Determine Market Characteristics
  • Coding and Reimbursement
    Web Sites
  • Using CLIA Certificate Data to target Marketing and Sales Efforts
• Briefings
  • 03/24/2025: OIG Report Shows 5% Drop in CLFS Spending
  • 02/13/2025: CLIA Waived Testing
  • 01/17/2025: Billing CPT 81479
  • 12/16/2024: January 1 Updates
  • 10/28/2024: 2025 Laboratory CPT Code Updates
• Return Policy
• About Us
  • Our location
  • Privacy Policy
  • Our Clients
  • Charles B. Root, Ph. D.
  • Gregory B. Root, Esq.
  • Jerry Tavolino
  • Linda Emmerich
  • Lara Tavolino
  • Abigail Tavolino
  • Pay an Invoice
  • Current W-9
  • Email Customer Service

837	CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC
838	CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT
839	CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC